PDCD1 and neoplasm: Although the detailed role of PD-1+ T cells in LNs remains unclear, recent mouse studies have demonstrated that LNs contained enriched PD-1+ tumor–specific progenitor T cells and that those PD-1+ T cells play an important role in PD-1 blockade–mediated antitumor immunity (46, 47).